An understanding of the crosstalk between the TGF-β1 and NF-κB pathways is crucial for deciphering the molecular mechanisms underlying various diseases, including colorectal cancer, and for identifying potential therapeutic targets. This evidence concerns the gene TGFB1 and colorectal cancer.